These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18094678)

  • 1. CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases.
    Obligado SH; Ibraghimov-Beskrovnaya O; Zuk A; Meijer L; Nelson PJ
    Kidney Int; 2008 Mar; 73(6):684-90. PubMed ID: 18094678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases.
    Soos TJ; Meijer L; Nelson PJ
    Drug News Perspect; 2006; 19(6):325-8. PubMed ID: 16971968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
    Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
    Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise synthesis and CDK/GSK inhibitory activity of the missing 9-azapaullones.
    Power DP; Lozach O; Meijer L; Grayson DH; Connon SJ
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4940-4. PubMed ID: 20621478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.
    Polychronopoulos P; Magiatis P; Skaltsounis AL; Myrianthopoulos V; Mikros E; Tarricone A; Musacchio A; Roe SM; Pearl L; Leost M; Greengard P; Meijer L
    J Med Chem; 2004 Feb; 47(4):935-46. PubMed ID: 14761195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
    Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
    Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic.
    Medina M; Castro A
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):533-43. PubMed ID: 18600569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the evaluation of CDK inhibitors as anti-tumor agents.
    McInnes C
    Drug Discov Today; 2008 Oct; 13(19-20):875-81. PubMed ID: 18639646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new dipyrrolo- and furopyrrolopyrazinones related to tripentones and their biological evaluation as potential kinases (CDKs1-5, GSK-3) inhibitors.
    Rochais C; Duc NV; Lescot E; Sopkova-de Oliveira Santos J; Bureau R; Meijer L; Dallemagne P; Rault S
    Eur J Med Chem; 2009 Feb; 44(2):708-16. PubMed ID: 18586356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
    Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
    Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
    Prével C; Kurzawa L; Van TN; Morris MC
    Eur J Med Chem; 2014 Dec; 88():74-88. PubMed ID: 25314935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-noncompetitive CDK inhibitors for cancer therapy: an overview.
    Abate AA; Pentimalli F; Esposito L; Giordano A
    Expert Opin Investig Drugs; 2013 Jul; 22(7):895-906. PubMed ID: 23735075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
    Yenugonda VM; Deb TB; Grindrod SC; Dakshanamurthy S; Yang Y; Paige M; Brown ML
    Bioorg Med Chem; 2011 Apr; 19(8):2714-25. PubMed ID: 21440449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
    Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
    J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs.
    Martinez A
    Med Res Rev; 2008 Sep; 28(5):773-96. PubMed ID: 18271054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy.
    Palomo V; Perez DI; Gil C; Martinez A
    Curr Med Chem; 2011; 18(20):3028-34. PubMed ID: 21651477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
    Beurel E; Blivet-Van Eggelpoël MJ; Kornprobst M; Moritz S; Delelo R; Paye F; Housset C; Desbois-Mouthon C
    Biochem Pharmacol; 2009 Jan; 77(1):54-65. PubMed ID: 18938143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CDK inhibitors in cancer research and therapy.
    Cicenas J; Valius M
    J Cancer Res Clin Oncol; 2011 Oct; 137(10):1409-18. PubMed ID: 21877198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.
    Kaubisch A; Schwartz GK
    Cancer J; 2000; 6(4):192-212. PubMed ID: 11038138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.